![]() |
![]() | ![]() |
We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
![]()
LCI is a small pharmaceutical company, listed on the Amex just last April. It makes both prescription and over-the-counter generic drugs. LCI closed today at $11.94 in a strong uptrend that does not mirror the biotech sector's horrible performance. The question to be answered is whether this uptrend can continue or if the stock is overpriced and subject to significant correction. Prior to the Amex listing, Lannett evidently traded OTCBB as LANN. The company web site is: lannett.com | ||||||||||||||
|
Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
© 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |